REG - AIM - AIM Notice - 07/04/2026

Faron Pharmaceuticals OyAnnouncement

Today 09:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260407:nRSG3208Za&default-theme=true

RNS Number : 3208Z  AIM  07 April 2026

NOTICE

 

07/04/2026 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 88 Energy Limited
 173,602,563  ORDINARY SHARES OF NO PAR VALUE FULLY PAID (DI)  (BW9NZW0)(AU00000088E2)

 

 Avacta Group Plc
 15,873,016  ORDINARY SHARES OF 10P EACH, FULLY PAID  (BYYW9G8)(GB00BYYW9G87)

 

 Faron Pharmaceuticals Oy
 80,158,126  INTERIM SHARES, FULLY PAID (DI)  (BNTYWK7)(FI4000602321)

 

 IQE plc                                             Block Admission
 22,000,000  ORDINARY SHARES OF 1P EACH, FULLY PAID  (0961992)(GB0009619924)

 

 Pulsar Helium Inc.
 250,000  COMMON SHARES OF NO PAR VALUE, FULLY PAID (DI)  (BS0CZX9)(CA7459321039)

 

 XP FACTORY PLC
 500,000  ORDINARY SHARES OF 1.25P EACH FULLY PAID  (BDB79J2)(GB00BDB79J29)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBUGDSSBGDGLD



            Copyright 2019 Regulatory News Service, all rights reserved